New Bill Would Give FDA Greater Development, Review Tools
Sen. Kay Hagan, D-N.C., proposed legislation Wednesday that she says would allow the U.S. Food and Drug Administration to advance investment in and development of new treatments and products for unmet medical...To view the full article, register now.
Already a subscriber? Click here to view full article